Optimal time to initiate anti-HIV therapy: clinical decisions without definitive data
Volberding, P.
Infectious Agents and Disease 1(3): 163-166
1992
ISSN/ISBN: 1056-2044 PMID: 1365541 Document Number: 403116
Document emailed within 1 workday
Related Documents
Albers, G.W.; Tijssen, J.G. 1999: Antiplatelet therapy: new foundations for optimal treatment decisions Neurology 53(7 Suppl 4: S25-S31Rosow, E.; Adam, J. 2000: Virtual instrumentation tools for real-time performance indicators: using PIVIT for data-driven decisions Biomedical Instrumentation and Technology 34(2): 99-104
Quinn, M. 2003: Reality management. Real-time data let hospital leaders base decisions on what's happening now, not last year Trustee: the Journal for Hospital Governing Boards 56(5): 8
Jespersen, J.; Hansen, M.S.; Dyerberg, J.; Ingerslev, J.; Jensen, G.; Jørgensen, M.; Laursen, B.; Nielsen, J.D.; Svendsen, T.L. 1991: Standardized prothrombin time determinations and optimal anticoagulant therapy Ugeskrift for Laeger 153(5): 355-360
Siegfried, N.; Uthman, O.A.; Rutherford, G.W. 2010: Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults Cochrane Database of Systematic Reviews 3: Cd008272
Kitano, I. 1980: A newly developed Sapporo IABP control system and experimental studies on optimal condition-especially "optimal deflation time" Nihon Kyobu Geka Gakkai 28(1): 111-123
Siegfried, N.; Davies, M-Ann.; Penazzato, M.; Muhe, L.M.; Egger, M. 2013: Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old Cochrane Database of Systematic Reviews 2013(10): Cd010309
Heumann, T.R.; Diaz, R.; Liu, Y.; Hanley, K.; Bang, S.; Horowitz, I.R.; Khanna, N.; Shelton, J.W. 2017: Clinical outcomes and the role of adjuvant therapy sequencing in Type Ii uterine cancer following definitive surgical treatment European Journal of Gynaecological Oncology 38(3): 404-412
Vijverberg Wpm 1984: Discrete choices in a continuous time model: life-cycle time allocation and fertility decisions Research in Population Economics 5: 51-85
Walker, J.M. 1999: Influence of data display formats on decisions to stop clinical trials. Paper is misleading, like a sheep dressed in a wolf's clothing Bmj 319(7216): 1070
Maqutu, D.; Zewotir, T. 2011: Optimal HAART adherence over time and time interval between successive visits: their association and determinants Aids Care 23(11): 1417-1424
Meintjes, G.; Black, J.; Conradie, F.; Dlamini, S.; Maartens, G.; Manzini, T.C.; Mathe, M.; Moorhouse, M.; Moosa, Y.; Nash, J.; Orrell, C.; Venter, F.; Wilson, D. 2015: Southern African HIV Clinicians Society adult antiretroviral therapy guidelines: Update on when to initiate antiretroviral therapy Southern African journal of HIV medicine 16(1): 428
Penn, C.L. 2009: Time is brain. Stroke--like trauma--demands immediate, definitive treatment Journal of the Arkansas Medical Society 105(11): 252-255
Romanò, M. 2011: Withholding and withdrawing therapy in cardiac intensive care units: ethical and clinical criteria in end-of-life decisions Giornale Italiano di Cardiologia 12(1): 50-57
Malecková, J. 1989: Development of demographic indicators in Czechoslovakia in 1987 and 1986 (1986--definitive data, 1987--preliminary data Ceskoslovenska Pediatrie 44(1): 29-32
Soulillou, J.P.; de Mouzon, A.; Peyrat, M.A.; Guenel, J. 1979: Role of anti-donor B lymphocyte antibodies in definitive allograft rejection Transplantation Proceedings 11(1): 770-775
Schellhammer, P.F.; Kuban, D.A.; el-Mahdi, A.M. 1991: Local failure after definitive radiation or surgical therapy for carcinoma of the prostate and options for prevention and therapy Urologic Clinics of North America 18(3): 485-499
Loubiere, S.; el Filal, K.M.; Sodqi, M.; Loundou, A.; Luchini, S.ép.; Cleary, S.; Moatti, J.-P.; Himmich, H. 2008: When to initiate highly active antiretroviral therapy in low-resource settings: the Moroccan experience Antiviral Therapy 13(2): 241-251
Herody, M.; Bobrie, G.; Gouarin, C.; Grünfeld, J.P.; Noel, L.H. 1993: Anti-GBM disease: predictive value of clinical, histological and serological data Clinical Nephrology 40(5): 249-255
Byśkiniewicz, K. 2006: Factors determining the decision to initiate nCPAP therapy in patients with obstructive sleep apnea (OSA) Pneumonologia i Alergologia Polska 74(1): 45-50